Our privacy policy describes how Fidessa uses cookies on our website. If you continue using our website, you are consenting to our use of cookies. OK


Point to your chosen market to compare and track levels of fragmentation, then click for a detailed analysis using the Fragulator®

The Future of Best Execution

I was chatting with a few work colleagues last Friday about best execution and derivatives. They confidently asserted that without real fungibility (i.e. the ability to trade the same instrument on different venues), price comparison is not possible and so any notion of best-ex was pretty meaningless.... Read More

If it ain’t broke, break it

I was hoping to enjoy the last few weeks of summer in relative peace, but it seems that another regulatory storm is brewing. This time it’s over the unbundling of research and it all stems from ESMA’s interpretation that, under MiFID II, research is an “inducement to trade” and therefore cannot... Read More

Re-thinking post-trade

If you watched our last video you will have seen how firms are re-engineering processes rather than just trying and do the same things more cheaply. Post-trade represents an ideal area for this type of thinking as it is dominated by old proprietary technologies and unnecessary duplication. On top of... Read More

An eye on the ‘new normal’

Our latest video looks at the key trends that characterise the ‘new normal’ in financial markets and how the most innovative firms are already adapting.  Read More

Build vs Buy becomes Rent vs Collaborate

An interesting couple of days at the International Derivatives Expo in London this week. Alongside the usual debate on OTC clearing, algo tagging and other regulatory conundrums, I was on a panel looking at the changing face of vendor relationships. What is evident is that the build vs buy debate has... Read More

Copyright © 2014 Fidessa group plc. All rights reserved.

The information contained within this website is provided for informational purposes only. Fidessa will use reasonable care to ensure that information is accurate at the time it is made available, and for the duration that it remains on the site. The information may be changed by Fidessa at any time without notice. We also reserve the right to close the website at any time. No representation or warranty, expressed or implied, is given on behalf of Fidessa or any of its respective directors, employees, agents, or advisers as to the accuracy or completeness of the information or opinions contained herein or its suitability for any purpose and, save in the case of fraud, all liability for direct, indirect, special, consequential or other loss or damages of whatever kind that may arise from use of the website is hereby excluded to the fullest extent permitted by law. Any decisions you make based on the information in this website are your sole responsibility and information on the website should not be relied upon in connection with any investment decision.

The copyright of this website belongs to Fidessa. All other intellectual property rights are reserved.

Fragulator® is a registered trademark of Fidessa group plc.

Reproduction or redistribution of this information is prohibited except with written permission from Fidessa.